SGYP - Synergy Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Synergy Pharmaceuticals's activity chart (see below) currently has 30 price targets and 26 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 52.5 days.

Most recent stock forecast was given by from CAPITAL ONE on 26-Oct-2018. First documented stock forecast 25-Aug-2015.

Best performing analysts who are covering SGYP - Synergy Pharmaceuticals:

Liav Abraham Derek Archila John Newman Tim Chiang William Tanner Michael Higgins

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Jun-2017

$8

$7.97 (26566.67%)

$11

Sell Since 27-Jun-2017

$2.5

$2.47 (8233.33%)

Buy Since 23-Dec-2016

$13

$12.97 (43233.33%)

$13

Show more analysts

Please expand the browser size to see the chart

What is SGYP (Synergy Pharmaceuticals) average time for price targets to be met?

On average it took 52.5 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on SGYP (Synergy Pharmaceuticals) with a proven track record?

LIAV ABRAHAM

Which analyst has the most public recommendations on SGYP (Synergy Pharmaceuticals)?

Liav Abraham works at CITI and has 3 price targets and 2 ratings on SGYP

Which analyst is the currently most bullish on SGYP (Synergy Pharmaceuticals)?

John Newman with highest potential upside - $12.97

Which analyst is the currently most reserved on SGYP (Synergy Pharmaceuticals)?

Derek Archila with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?